{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T21:03:32Z","timestamp":1649192612784},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.hlc.2005.01.003","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T07:45:26Z","timestamp":1115883926000},"page":"87-89","source":"Crossref","is-referenced-by-count":1,"title":["A Unique Presentation of Antiphospholipid Antibody Syndrome in Pregnancy"],"prefix":"10.1016","volume":"14","author":[{"given":"A.P.","family":"Gunasekara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Meulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hlc.2005.01.003_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0889-857X(05)70315-X","article-title":"Antiphospholipid Syndrome in pregnancy. Obstetric concerns and treatment","volume":"23","author":"Welsch","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.hlc.2005.01.003_bib2","first-page":"131","article-title":"A study of sixty pregnancies in patients with antiphospholipid syndrome","volume":"14","author":"Lima","year":"1996","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.hlc.2005.01.003_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00003081-200103000-00003","article-title":"Mechanisms of pregnancy loss in antiphoslipid syndrome","volume":"44","author":"Gharavi","year":"2001","journal-title":"Clin Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.hlc.2005.01.003_bib4","first-page":"431","article-title":"A case of primary antiphospholipid antibody syndrome with severe nephrotic syndrome showing remarkable endothelial cell damage in the capillary lumen","volume":"39","author":"Nakano","year":"1997","journal-title":"Jpn J Nephrol"},{"issue":"3","key":"10.1016\/j.hlc.2005.01.003_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1385\/CRIAI:23:3:341","article-title":"Cardiac valvulopathy in the antiphospholipid syndrome","volume":"23","author":"Lev","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"10.1016\/j.hlc.2005.01.003_bib6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0894-7317(97)70050-6","article-title":"Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome","volume":"10","author":"Agirbasli","year":"1997","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"10.1016\/j.hlc.2005.01.003_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11926-000-0089-4","article-title":"Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis","volume":"2","author":"Amigo","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.hlc.2005.01.003_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0002-8703(96)90313-0","article-title":"Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: a case control study","volume":"132940","author":"Bouillanne","year":"1996","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.hlc.2005.01.003_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4065\/78.3.294","article-title":"Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease","volume":"78","author":"Bulckaen","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.hlc.2005.01.003_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0049-0172(97)80034-0","article-title":"Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment","volume":"27","author":"Nesher","year":"1997","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.hlc.2005.01.003_bib11","first-page":"425","article-title":"Cardiac involvement in connective tissue disease and primary antiphospholipid syndrome: echocardiographic assessment and correlation with antiphospholipid antibodies","volume":"51","author":"Gabrielli","year":"1996","journal-title":"Acta Cardiol"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950605000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950605000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T10:25:46Z","timestamp":1548498346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950605000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1443950605000259"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2005.01.003","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}